Honoring Achievement in the Regulatory Field
U.S Food and Drug Administration
Co-founded by Johnson & Johnson and New York University
Rooted in the belief that critical decisions benefit from objective input separate from commercial interests, the Compassionate Use Advisory Committee (CompAC) consists of external bioethicists, medical experts, and patient representatives to apply an equitable method to the evaluation of expanded access requests. Learnings from CompAC have informed the pre-approval access approach at GE2P2 Global Foundation at NYU School of Medicine.
The Cystic Fibrosis Foundation is responsible for nearly every Cystic Fibrosis drug available today. At all levels of government, the CFF supports and influences legislation that benefits people living with the disease. The CFF serves as an advocate by mobilizing the CF community nationwide to engage with their representatives on matters impacting their health.